Kyu-Don Kim
Corporate Officer/Principal bei GENEXINE, INC.
Aktive Positionen von Kyu-Don Kim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENEXINE, INC. | Corporate Officer/Principal | - | - |
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Geschäftsführer | - | - |
Karriereverlauf von Kyu-Don Kim
Ehemalige bekannte Positionen von Kyu-Don Kim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHONG KUN DANG PHARMACEUTICAL CORP. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 30.09.2014 | - | |
Corporate Officer/Principal | 23.05.2014 | - |
Ausbildung von Kyu-Don Kim
Northern Illinois University | Doctorate Degree |
Statistik
International
Südkorea | 3 |
Vereinigte Staaten | 2 |
Indonesien | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CHONG KUN DANG PHARMACEUTICAL CORP. | Health Technology |
GENEXINE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Health Technology |
- Börse
- Insiders
- Kyu-Don Kim
- Erfahrung